【発明の名称】カンディダアルビカンスからの新規TFIIB転写ファクター、それをコード化する核酸配列、及びカンディダアルビカンス増殖の阻害のためのスクリーニング方法

Title:

Document Type and Number:

Japanese Patent JP2001501809

Kind Code:

A

Abstract:

The invention encompasses a novel transcription factor from Candida albicans, TFIIB, a nucleic acid sequence encoding TFIIB, and methods of screening for inhibitors of Candida albicans growth by targeting TFIIB.

More Like This:

JP5860573	Compstatin analog with improved activity
WO/2002/090974	METHOD FOR DETECTING PROGREDIENT CHRONIC DEMENTIA, AND ASSOCIATED PEPTIDES AND DETECTION REAGENTS
WO/2019/009985	SPECIALIZED EXCITATORY SYNAPTIC PROTEIN BIOMARKERS OF PLASMA NEURONAL EXOSOMES FOR PREDICTION AND STAGING OF ALZHEIMER'S DISEASE

Inventors:

Bratowski, Stephan
Wobbe See, Richard
Bradley, John

Application Number:

JP53563297A

Publication Date:

February 13, 2001

Filing Date:

March 31, 1997

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Scriptgen Pharmaceuticals, Inc.
President and Fellows of Harvard College

International Classes:

G01N33/50; A61K45/00; C07K14/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12P21/02; C12Q1/68; G01N33/15; A61K38/00; C12R1/725; (IPC1-7): C12N15/09; A61K31/10; A61K45/00; C07K14/40; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; C12Q1/68; G01N33/15; G01N33/50

Attorney, Agent or Firm:

Masatake Shiga (1 person outside)

Previous Patent: 歯周炎の診断および治療用のポルフィロモナス・ジンジバリス抗原

Next Patent: 遺伝子発現の増強